Financials 5N Plus Inc.

Equities

VNP

CA33833X1015

Specialty Chemicals

Delayed Toronto S.E. Other stock markets 14:00:17 2024-04-29 EDT			5-day change	1st Jan Change
4.76 ^CAD	-1.65%		-2.46%	+25.93%

04-18	Toronto Stocks Advance; Lithium Americas Shares Down on Discounted Pricing for $275 Million Public Offering	DJ
04-18	5n Plus Up More Than 2% After US Department of Defense Awards It a US$14.4 Million Contract	MT

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Capitalization ¹	157.8	189.4	166.3	189.6	252.9	313.9	-
Enterprise Value (EV) ¹	192.9	199.5	246.3	267.9	326.7	389.6	371.1
P/E ratio	94.6 x	77.2 x	47.1 x	-8.25 x	16.8 x	16.8 x	12.6 x
Yield	-	-	-	-	-	-	-
Capitalization / Revenue	0.81 x	1.07 x	0.79 x	0.72 x	1.04 x	1.13 x	1.02 x
EV / Revenue	0.98 x	1.13 x	1.17 x	1.01 x	1.35 x	1.4 x	1.2 x
EV / EBITDA	8.79 x	6.93 x	8.72 x	8.92 x	8.53 x	8.26 x	6.78 x
EV / FCF	-28.5 x	7.49 x	99.6 x	72.7 x	-84.9 x	29.5 x	19.1 x
FCF Yield	-3.51%	13.4%	1%	1.38%	-1.18%	3.39%	5.23%
Price to Book	-	-	-	-	-	-	-
Nbr of stocks (in thousands)	83,402	81,763	88,330	88,330	88,705	88,790	-
Reference price ²	1.892	2.316	1.882	2.146	2.851	3.536	3.536
Announcement Date	20-02-25	21-02-23	22-02-22	23-02-21	24-02-28	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Net sales ¹	196	177.2	210	264.2	242.4	278.3	308
EBITDA ¹	21.95	28.79	28.24	30.03	38.32	47.2	54.77
EBIT ¹	12.28	17.07	17.47	15	22.21	32	40.6
Operating Margin	6.27%	9.63%	8.32%	5.68%	9.16%	11.5%	13.18%
Earnings before Tax (EBT) ¹	3.833	7.209	8.74	-18.29	18.67	22	28.3
Net income ¹	1.785	2.186	3.11	-23	15.4	16.8	21.75
Net margin	0.91%	1.23%	1.48%	-8.7%	6.35%	6.04%	7.06%
EPS ²	0.0200	0.0300	0.0400	-0.2600	0.1700	0.2100	0.2800
Free Cash Flow ¹	-6.766	26.65	2.472	3.687	-3.85	13.2	19.4
FCF margin	-3.45%	15.04%	1.18%	1.4%	-1.59%	4.74%	6.3%
FCF Conversion (EBITDA)	-	92.57%	8.75%	12.28%	-	27.97%	35.42%
FCF Conversion (Net income)	-	1,219.26%	79.49%	-	-	78.57%	89.2%
Dividend per Share	-	-	-	-	-	-	-
Announcement Date	20-02-25	21-02-23	22-02-22	23-02-21	24-02-28	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1
Net sales ¹	50.84	64.56	64.42	72.39	66.37	61.04	55.29	59.08	62.95	65.06	65.37	67.8	72	74.73	-
EBITDA ¹	5.537	10.09	5.626	8.583	9.114	6.705	8.797	10.84	9.649	9.033	10.2	11.15	12.65	13.22	12.8
EBIT ¹	2.566	7.486	0.797	3.727	5.118	5.356	4.738	6.829	5.67	4.976	6.8	7.5	8.3	9.5	-
Operating Margin	5.05%	11.6%	1.24%	5.15%	7.71%	8.77%	8.57%	11.56%	9.01%	7.65%	10.4%	11.06%	11.53%	12.71%	-
Earnings before Tax (EBT) ¹	1.173	2.294	-6.283	0.499	-4.066	-8.438	2.451	11.46	3.214	1.55	4.2	4.6	6.2	7	-
Net income ¹	-0.792	0.98	-5.755	-2.13	-6.968	-8.146	1.454	10.14	1.518	2.284	3.3	3.7	4.5	5.3	-
Net margin	-1.56%	1.52%	-8.93%	-2.94%	-10.5%	-13.34%	2.63%	17.17%	2.41%	3.51%	5.05%	5.46%	6.25%	7.09%	-
EPS ²	-0.0100	0.0100	-0.0700	-0.0200	-0.0800	-0.0900	0.0200	0.1100	0.0200	0.0300	0.0400	0.0500	0.0600	0.0700	-
Dividend per Share	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	21-11-02	22-02-22	22-05-04	22-08-02	22-11-01	23-02-21	23-05-03	23-08-01	23-11-07	24-02-28	-	-	-	-	-

¹USD in Million²USD

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Net Debt ¹	35	10.2	80.1	78.3	73.8	75.7	57.1
Net Cash position ¹	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	1.596 x	0.3529 x	2.835 x	2.608 x	1.926 x	1.604 x	1.043 x
Free Cash Flow ¹	-6.77	26.7	2.47	3.69	-3.85	13.2	19.4
ROE (net income / shareholders' equity)	-	-	-	-	-	-	-
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-
Book Value Per Share	-	-	-	-	-	-	-
Cash Flow per Share	-	-	-	-	-	-	-
Capex ¹	-	8.42	5.39	16.1	17.3	16	16
Capex / Sales	-	4.75%	2.56%	6.08%	7.15%	5.75%	5.19%
Announcement Date	20-02-25	21-02-23	22-02-22	23-02-21	24-02-28	-	-

¹USD in Million

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for 5N Plus Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.536 USD

Average target price

4.356 USD

Spread / Average Target

+23.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
5N PLUS INC.	+25.93%	314M
ECOLAB INC.	+11.70%	63.22B
SIKA AG	-3.51%	46.34B
GIVAUDAN SA	+13.09%	39.97B
FUJIFILM HOLDINGS CORPORATION	+17.83%	25.46B
EMS-CHEMIE HOLDING AG	+8.37%	18.68B
CELANESE CORPORATION	+1.20%	17.24B
POSCO FUTURE M CO., LTD.	-20.33%	15.81B
SYMRISE AG	+0.36%	14.9B
ALBEMARLE CORPORATION	-13.26%	13.74B

Other Specialty Chemicals